bioRxiv·31 AugCerebrospinal fluid YWHAG:NPTX2 ratio predicts clinical severity and future phenoconversion in frontotemporal lobar degenerationPreprint: cohort study in peopleBiomarkersPaper
Research Square·7 AugProximity-extension dementia-panel in 41 brain disorders: a meta-analysisPreprint: study in peopleBiomarkersPaper
Brain Communications·5 AugEducational attainment and sex modulate clinical outcomes in genetic frontotemporal dementiaStudy in peoplePopulationsPaper
Research Square·4 AugThe Ignite app detects early cognitive impairment and tracks disease severity in genetic frontotemporal dementiaPreprint: study in peopleBiomarkersPaper
AAIC 2025 Abstract·7 JanCharacterising real‐world macro walking outcomes of people with Posterior Cortical Atrophy using accelerometery: Feasibility and preliminary comparison with Alzheimer's and Lewy body diseaseStudy in peoplePopulationsPaper
AAIC 2025 Abstract·26 DecTMEM106B modulates disease severity in genetic frontotemporal dementia phenoconvertersStudy in peoplePopulationsPaper
AAIC 2025 Abstract·25 DecStructure‐function decoupling in genetic frontotemporal dementiaStudy in peopleMechanismsPaper
AAIC 2025 Abstract·23 DecCharacterising real‐world macro walking outcomes of people with Posterior Cortical Atrophy using accelerometery: Feasibility and preliminary comparison with Alzheimer's and Lewy body diseaseStudy in peoplePopulationsPaper
AAIC 2025 Abstract·23 DecNULISA analysis in genetic frontotemporal dementia: a study on the GENetic FTD InitiativeStudy in peopleBiomarkersPaper